Mindray Medical International (MR) Tops Q2 EPS by 9c, Offers Guidance
Tweet Send to a Friend
Mindray Medical International (NYSE: MR) reported Q2 EPS of $0.56, $0.09 better than the analyst estimate of $0.47. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
